IVF Screening Panel
Summary
Women undergoing in
vitro fertilization (IVF) for treatment of infertility not due solely to
male factor have an increased prevalence of immunologic risk factors.
Thus, women with a female factor or unexplained infertility are screened
prior to starting an IVF cycle to rule out a treatable cause of potential
implantation failure.
Women with endometriosis, pelvic adhesions, unexplained infertility,
secondary infertility after a history of recurrent spontaneous
miscarriages and family history of autoimmune disease should be screened
with a minimum of the routine screening tests. However, depending upon the
patient history, immunologic testing should be individualized. Some
patients may require additional testing. Women who have had a cumulative 8
or more embryos transferred or 4 or more blastocysts transferred without
successful pregnancy should have evaluation with the Implantation Failure
Panel (below).
Panel Tests Included
Anti-phospholipid antibodies
(APA), anti-thyroid
antibodies (ATA) and NK activation assay
(NKa).
Specimen Collection and Shipping
Requirements
- Collect one (1) 10 ml red or tiger top tube and one (1) green top
tube.
- Ship at room temperature in prepaid FedEx mailers overnight, next
day morning.
Turn Around Time
Processing of specimens
begins immediately upon receipt at our facilities. Results are routinely
available within 7 to 10 days and are initially faxed, then mailed to the
requesting physician.
Cost
Included in our fees are specimen
collection and shipping materials, all courier and shipping charges,
telephone and written reports, and consultation with physicians. Please
call (312) 274-1928 for pricing information.
Request Hard Copy
| 
